References
- Drossman DA, Whitehead WE, Camilleri M. Irritable bowel syndrome: a technical review for practice guideline development. Gastroenterology 1997;112:2120–37
- Saito, YA, Schoenfeld P, Locke GR. The epidemiology of irritable bowel syndrome in North America: a systematic review. Am J Gastroenterol 2002;97:1910–15
- Camilleri M, Choi MG. Review article: irritable bowel syndrome. Aliment Pharmacol Ther 1997;11:3–15
- Heaton KW, O’Donnell LJ, Braddon FE, Mountford RA, Hughes AO, Cripps PJ. Symptoms of irritable bowel syndrome in a British urban community: consulters and nonconsulters. Gastroenterology 1992;102:1962–7
- Mayer EA, Naliboff B, Lee O, Munakata J, Chang L. Review article: gender-related differences in functional gastrointestinal disorders. Aliment Pharmacol Ther 1999;13(Suppl 2):65–9
- Sandler RS. Epidemiology of irritable bowel syndrome in the United States. Gastroenterology 1990;99:409–15
- Brandt LJ, Bjorkman D, Fennerty MB, et al. Systemic review on the management of irritable bowel syndrome in North America. Am J Gastronenterol 2002;11(Suppl):s7–26
- Hasler WL. The irritable bowel syndrome. Med Clin N Am 2002;86:1525–51
- Mitchell CM, Drossman DA. Survey of the AGA membership relating to patients with functional gastrointestinal disorders. Gastroenterology 1987;92:1282–4
- Everhart JE, Renault PF. Irritable bowel syndrome in office-based practice in the United States. Gastroenterology 1991;100:998–1005
- Martin R, Barron JJ, Zacker C. Irritable bowel syndrome: toward a cost-effective management approach. Am J Manag Care 2001;7(Suppl 8):S268–75
- American Gastroenterological Association. The burden of gastrointestinal diseases. 2001;1–86
- American Heart Association. 2002 Heart and stroke statistical update. 2002;1–35
- Ricci JF, Jhingran P, McLaughlin T, Carter EG. Costs of care for irritable bowel syndrome in managed care. J Clin Outcomes Manag 2000;7:23–8
- Talley NJ, Gabriel SE, Harmsen WS, Zinsmeister AR, Evans RW. Medical costs in community subjects with irritable bowel syndrome. Gastroenterology 1995;109:1736–41
- Leong SA, Barghout V, Birnbaum HG, et al. The economic consequences of irritable bowel syndrome: a US employer perspective [abstract]. Am J Gastroenterol 2000;96 (Suppl 9):S320
- Levy RL, Von Korff M, Whitehead WE, et al. Costs of care for irritable bowel syndrome patients in a health maintenance organization. Am J Gastroenterol 2001;96:3122–9
- Manning WG. The logged dependent variable, heteroscedasticity, and the retransformation problem. J Health Econ 1998;17:283–95
- Risk Adjustment for Measuring Healthcare Outcomes, 2nd edn. Chicago, Il: Health Administration Press, 1997
- Ricci JF, Dorfman JH, Martin BC. Development and validation of prospective cost risk adjustment indices using administrative medical and drug information for Medicaid populations. Poster presented at: Academy for Health Services Research and Health Policy, Annual Meeting, June 2001, Atlanta, Ga
- SAS Institute Inc. SAS User’s Guide. Cary, NC: SAS Institute Inc, 1992
- STATA Corporation. STATA Reference Manual. Release 6.0 edn. College Station, Tx: STATA Corporation, 1999
- Pannicker S, Nielsen K, Martin BC. The net cost of asthma to a US public Medicaid program [abstract]. Value Health 2001;4:419
- Zacker C, White LA, Wang S, et al. Patterns of outpatient prescription drug use and related costs in irritable bowel syndrome [abstract]. Presented at: Drug Information Association Annual Meeting, June 22, 2000, San Diego, Ca
- Kay L, Jorgensen T, Jensen KH. The epidemiology of irritable bowel syndrome in a random population: prevalence, incidence, natural history and risk factors. J Intern Med 1994;236:23–30
- Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology 2002;122:1140–56
- Drossman DA, McKee DC, Sandler RS, et al. Psychosocial factors in the irritable bowel syndrome: a multivariate study of patients and nonpatients with irritable bowel syndrome. Gastroenterology 1988;95:701–8
- Drossman DA, Creed FH, Olden KW, Svedlund J, Toner BB, Whitehead WE. Psychosocial aspects of the functional gastrointestinal disorders. Gut 1999;45(Suppl 2):II25–30
- Crowell MD, Schettler-Duncan A, Dennis EH, et al. Psychosocial function among IBS consulters [abstract]. Am J Gastroenterol 2002;97:S281–2
- Drossman DA, Li Z, Andruzzi E, et al. US householder survey of functional gastrointestinal disorders: prevalence, sociodemography, and health impact. Dig Dis Sci 1993;38:1569–80
- Talley NJ, Zinsmeister AR, Van Dyke C, Melton LJI. Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology 1991;101:927–34
- Paterson WG, Thompson WG, Vanner SJ, et al. Recommendations for the management of irritable bowel syndrome in family practice: IBS Consensus Conference Participants. Can Med Assoc J 1999;161:154–60
- American Gastroenterological Association. American Gastroenterological Association medical position statement: irritable bowel syndrome. Gastroenterology 1997;112:2118–19
- Fass R, Longstreth GF, Pimentel M, et al. Evidence- and consensus-based practice guidelines for the diagnosis of irritable bowel syndrome. Arch Intern Med 2001;161:2081–8
- Brandt LJ, Locke GR, Olden K, et al. An evidence based approach to the management of irritable bowel syndrome in North America. Am J Gastroenterol 2002;97(Suppl):S28